Paychex stock price target lowered to $126 from $140 at TD Cowen

Paychex (PAYX) reported Q1 FY26 adjusted EPS of $1.22, slightly surpassing forecasts, and revenue of $1.54 billion, meeting expectations, with strong gross profit margins and reaffirmed fiscal year outlooks. Despite these inline results, multiple analysts, including TD Cowen, Wolfe Research, Stifel, BMO Capital, and RBC Capital, lowered their price targets and maintained cautious ratings, citing Wall Street skepticism regarding future growth acceleration, integration challenges, and underperformance in key segments like PEO and Insurance Solutions. This widespread analyst caution indicates that despite the company's performance, the investment narrative remains challenged by concerns over its future growth trajectory, with the stock trading near its 52-week low.

Analysis

Paychex (PAYX) delivered a first-quarter fiscal 2026 performance that, while solid on the surface, has been met with significant caution from the analyst community. The company reported an adjusted EPS of $1.22, narrowly beating forecasts, on revenue of $1.54 billion, which represented a 17% increase and met expectations. Furthermore, Paychex showcased strong fundamentals with a gross profit margin of 72.8% and reaffirmed its full-year growth and margin outlook. However, this has not been sufficient to bolster investor confidence, as evidenced by a wave of price target reductions from firms including TD Cowen, Wolfe Research, Stifel, and BMO Capital. The core issue is widespread skepticism on Wall Street regarding the company's forecasted acceleration in its Management Solutions (MS) and Professional Employer Organization and Insurance (PEO&I) segments. Specific concerns cited include integration challenges with Paycor, general business uncertainties, and a revenue shortfall in the PEO and Insurance Solutions division. This disconnect between the company's stable reported results and analyst doubts about its future trajectory has left the investment narrative unchanged and is reflected in the stock trading near its 52-week low despite a P/E ratio of 28.8.

Key Decisions for Investors

• Investors should exercise caution, as the widespread price target cuts and neutral-to-negative ratings from multiple analysts signal significant skepticism about the company's ability to achieve its forward-looking growth targets.
• It is critical to monitor revenue growth and margins within the PEO & Insurance and Management Solutions segments in subsequent quarters, as Wall Street's concerns are heavily concentrated on the forecasted acceleration in these specific divisions.
• Given the stock is trading near its 52-week low but still carries a relatively high P/E ratio of 28.8, the risk/reward profile may be unfavorable until there is tangible proof of successful integration and a validated growth re-acceleration.